Specialty code 175F00000X · Portland, OR
NPI
1306017884
Since 2008
Specialty
Specialty code 175F00000X
Code 175F00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3144 NE 64th Ave
Portland, OR, 97213
Phone (503) 453-9485
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$206K
561 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Alena G Guggenheim prescribed most often to Medicare patients was Cromolyn Sodium, with 70 prescriptions and refills. In total Alena G Guggenheim wrote 561 Medicare prescriptions that cost $206K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-12.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Cromolyn Sodium Generic | 70 | 126 | 19 | $80K |
| Pyridostigmine Bromide Generic | 54 | 90 | 13 | $3,141 |
| Desmopressin Acetate Generic | 29 | 40 | Under 11 | $1,292 |
| Potassium Chloride Generic | 23 | 51 | Under 11 | $253 |
| Propranolol Hcl Generic | 21 | 28 | Under 11 | $213 |
| Tramadol Hcl Generic | 19 | 19 | Under 11 | $82.23 |
| Clonidine Hcl Generic | 16 | 22 | Under 11 | $9.4 |
| Hydroxyzine Hcl Generic | 15 | 28 | Under 11 | $102 |
| Fludrocortisone Acetate Generic | 15 | 33 | Under 11 | $337 |
| Gabapentin Generic | 14 | 18 | Under 11 | $110 |
| Droxidopa Generic | 13 | 13 | Under 11 | $68K |
| Cyproheptadine Hcl Generic | 12 | 12 | Under 11 | $75.39 |
| Pyridostigmine Bromide Er Pyridostigmine Bromide | 11 | 25 | Under 11 | $4,702 |
| Tizanidine Hcl Generic | 11 | 11 | Under 11 | $266 |
Brand drugs: 40 claims; generic drugs: 521 claims; opioid claims: 42.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Alena G Guggenheim were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.